SWAN is pleased to announce an initial investment in Relavo.
Relavo is a medical device company that is changing the way that kidney failure patients receive treatment. Founded by an all-female team of biomedical engineers from Johns Hopkins University, Relavo is seeking to make home dialysis more accessible by minimizing the risk of infection with their technology, the PeritoneX. The PeritoneX is a novel connection device that reduces the risk of infection in peritoneal dialysis. Rather than connecting tubes directly, patients will connect them to the PeritoneX, which then internally disinfects the connected tubes with an antimicrobial solution. By reducing the risk of infection, patients will receive safer treatment.